Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract
Integrated Chemical and Proteomic Analysis of Aqueous Humor and Ocular Tissues in Glaucoma and Cataract Patients
2 other identifiers
interventional
40
1 country
2
Brief Summary
This observational study will compare proteomic and elemental profiles of aqueous humor and ocular tissues in patients with primary open-angle glaucoma (POAG) and cataract versus cataract controls without glaucoma. Samples collected during standard surgery will be analyzed using LC-MS/MS and ICP-MS. The goal is to identify glaucoma-associated molecular patterns with potential diagnostic or prognostic relevance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2026
CompletedFirst Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
March 10, 2026
January 1, 2026
1 year
February 9, 2026
March 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
IOP
Intraocular Pressure
Through study completion, an average of 1 year
Visual Field
Visual Field of the mean defect (MD)
Through study completion, an average of 1 year
BCVA
Best-corrected visual acuity
Through study completion, an average of 1 year
Protein expression
Measured by ICP-MS/LC-MS
Through study completion, an average of 1 year
RNFL
Retinal Nerve Fiber Layer (OCT)
Through study completion, an average of 1 year
Secondary Outcomes (1)
Medications
Through study completion, an average of 1 year
Study Arms (2)
Glaucoma + Cataract Group
EXPERIMENTALCataract Control Group
ACTIVE COMPARATORInterventions
Standard-of-care cataract surgery (phacoemulsification with intraocular lens implantation). Intraoperative collection of aqueous humor and routinely removed ocular tissue (anterior lens capsule) is performed for research analyses.
Standard-of-care combined cataract surgery (phacoemulsification with intraocular lens implantation) performed together with deep sclerectomy for glaucoma management. Intraoperative collection of aqueous humor and routinely removed ocular tissues (such as sclera and anterior lens capsule) is performed for research analyses.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Scheduled for cataract surgery (phacoemulsification with intraocular lens implantation).
- Ability to provide written informed consent.
- For glaucoma arm: diagnosis of primary open-angle glaucoma (POAG) with coexisting cataract, and planned combined cataract surgery with glaucoma procedure.
- For control arm: cataract without glaucoma and without other significant ocular pathology.
You may not qualify if:
- Age \< 18 years.
- Pregnancy or breastfeeding.
- Advanced visual impairment in the study eye (visual aquity worse than counting fingers).
- Any glaucoma type other than primary open-angle glaucoma (e.g., angle-closure, secondary, neovascular glaucoma).
- History of intraocular surgery in the study eye (including glaucoma surgery), vitreoretinal surgery, corneal transplantation, or refractive surgery.
- Active or previous uveitis.
- Other significant chronic ocular disease in the study eye (other than cataract and POAG in the glaucoma arm).
- Inability to comply with study procedures or follow-up visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Military Institute of Medicine - National Research Institute
Warsaw, Poland
University of Warsaw
Warsaw, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marek Rękas, MD, PhD
Military Institute of Medicine National Research Institute
- PRINCIPAL INVESTIGATOR
Ewa Bulska, PhD
University of Warsaw
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
March 10, 2026
Study Start
January 21, 2026
Primary Completion (Estimated)
January 21, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
March 10, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share